Key Takeaways Intuit Q2 EPS $4.15 beats estimates as revenue jumps 17% to $4.65B.INTU Global Business Solutions revenue up 18%, QuickBooks Online up 24%.Intuit reaffirms FY26 revenue view of $20.997B-$21.186B, EPS $22.98-$23.18; Q3 EPS guide $12.45-$12.51.Intuit (INTU) reported second-quarter fiscal 2026 non-GAAP earnings per share (EPS) of $4.15, which beat the Zacks Consensus Estimate of $3.66. The bottom line jumped 25% from the year-ago quarter.The company delivered fiscal second-quarter 2026 revenues o ...

Key Takeaways Realty Income plans about $8B in 2026 investments after deploying $6.3B in 2025.O expanded into Mexico and secured $1.5B funds plus a GIC partnership to fuel growth.O funded deals via ATM equity, raising $2.4B in 2025 while keeping underwriting disciplined.Realty Income (O) is leaning hard on acquisitions and strategic investments as it enters 2026. The company generated $6.3 billion (pro-rata share was $6.2 billion) of total investment volume in 2025, with $2.4 billion (pro-rata share was $2. ...

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Klarna Bank AB ((NYSE: KLAR): Klarna Bank AB, a subsidiary of Klarna Holding AB, published its 2025 Annual Report today at 8:30 PM CET. It is now available on Klarna's Investor Relations website. ...

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...

Shares of credit card and payments company American Express (NYSE: AXP) fell sharply on Friday, even though there was no new company-specific disclosure from Amex itself. The selling pressure came amid a broader fear that AI (artificial intelligence) could trigger meaningful white-collar job disruption, eventually showing up in consumer spending trends and credit performance. Is this sharp sell-off in the stock price, which has put shares down by about 15% year to date, a buying opportunity? Or should in ...

Key insight: Preferred Bank has moved a $115 million block of loans, which are backed by multifamily and commercial real estate properties, to nonaccrual status.What's at stake: The $7.6 billion-asset Preferred is the latest bank to be ensnared in a saga involving alleged borrower fraud. Both Zions Bancorp. and Western Alliance Bancorp. have sued the entities, whose lawyer has denied wrongdoing.Forward look: Preferred believes it can resolve the nonaccrual credits by the end of the second quarter.Los Angele ...

BOCA RATON, FL / ACCESS Newswire / February 27, 2026 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced that more than four million Americans tuned in across the Company's channels for the network's comprehensive live coverage of President Donald Trump's State of the Union address Tuesday night. The coverage marks a major ratings and digital milestone for the Company. ...

What Now: You may be eligible to participate in the class action against Ardent Health, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by March 9, 2026. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All r ...

Duolingo Stock Falls 20% After Earnings. Why Wall Street Is Spooked. - Barron'sSkip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.# Duolingo Stock Plummets 20%. Why a Strategy Shake-Up Is Spooking Wall Street.By [Mackenzie Tatananni]and [George Glover]Sha ...

New York, New York--(Newsfile Corp. - February 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between August 3, 2023 and December 26, 2025, inclusive (the "Class Period"), of the important April 6, 2026 lead plaintiff deadline. SO WHAT: If you purchased Ultragenyx common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a conting ...